Evidence map›Paper›PMID 42339958›Full record

ArticleGenetics research2026

Biological Context-Informed and Population-Stratified Strategies Improve Genetic Diagnosis of CCDC22-Related Disorder.

Pei-Qi Zhang, Peng-Yu Wang, Si-Qi Zhang, Yan Ding, Wen-Hui Liu, Yao Wang, Kai Peng, Hua Li, Sheng Luo, Heng Meng and 1 more

Abstract read
In one paragraph

Article in Genetics research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pei-Qi ZhangEpilepsy Center, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong, China.
Peng-Yu WangInstitute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China, gzhmc.edu.cn.ORCID 0009-0001-6848-2021
Si-Qi ZhangDepartment of Neurology, The First Affiliated Hospital & Clinical Neuroscience Institute of Jinan University, Guangzhou, Guangdong, China.ORCID 0009-0009-6657-289X
Yan DingDepartment of Neurology, The First Affiliated Hospital & Clinical Neuroscience Institute of Jinan University, Guangzhou, Guangdong, China.
Wen-Hui LiuDepartment of Neurology, The First Affiliated Hospital & Clinical Neuroscience Institute of Jinan University, Guangzhou, Guangdong, China.ORCID 0009-0002-9254-711X
Yao WangEpilepsy Center, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong, China.ORCID 0009-0006-8327-4390
Kai PengEpilepsy Center, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong, China.
Hua LiEpilepsy Center, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong, China.ORCID 0000-0002-7957-7886
Sheng LuoInstitute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China, gzhmc.edu.cn.ORCID 0000-0002-7184-1267
Heng MengDepartment of Neurology, The First Affiliated Hospital & Clinical Neuroscience Institute of Jinan University, Guangzhou, Guangdong, China.ORCID 0000-0002-8859-6042
Jing GuoEpilepsy Center, Guangdong Sanjiu Brain Hospital, Guangzhou, Guangdong, China.ORCID 0000-0002-6062-9527

Funding

Medical Scientific Research Foundation of Guangdong Province A2024536
6 · The paper itself

Abstract

backgroundThe CCDC22 gene is a key regulator of endosomal trafficking and NF-κB signaling, and its dysfunction is implicated in a spectrum of X-linked neurodevelopmental disorders, including Ritscher-Schinzel syndrome 2, intellectual disability, and epilepsy. Despite the identification of CCDC22 variants having increased, a comprehensive biological characterization, including its spatiotemporal expression and functional molecular networks, remains to be systematically delineated. Furthermore, the rarity of CCDC22 variants created a significant challenge in distinguishing their pathogenicity. This study aimed to explore the integration of biological context-informed and clinical genetic analysis workflows and to perform an exploratory evaluation of prediction algorithms to better optimize the genetic diagnosis process for CCDC22.

methodsMultilevel biological analysis was performed to evaluate the spatiotemporal expression patterns of CCDC22 across developmental stages. A protein-protein interaction network was constructed to identify key functional modules and pathway enrichments. Additionally, an expert-classified dataset of CCDC22 missense variants was utilized to conduct an exploratory performance evaluation of twenty prediction algorithms, specifically assessing the effect of filtering out variants observed as population hemizygotes.

resultCCDC22 exhibits distinct spatiotemporal expression dynamics and chromatin accessibility patterns closely associated with neurodevelopmental processes. PPI and functional enrichment analyses highlighted its core involvement in endocytic recycling and vesicle transport. In the exploratory missense variant evaluation, meta-predictors, notably ClinPred and MetaRNN, demonstrated the highest predictive potential within this limited cohort. After filtering out variants observed as hemizygotes in the gnomAD database, most of the algorithms' performance improved in distinguishing the pathogenicity of variants and genetic diagnosis. ClinPred, M-CAP, MetaRNN, and SIFT achieved the highest balanced accuracy (84.6%, 80.8%, 78.7%, and 76.1%, respectively). ClinPred, M-CAP, and MetaRNN achieved the highest AUC value (> 0.9).

conclusionThis study delineates the spatiotemporal and functional molecular network of CCDC22 in neurodevelopment. A combination of population-based strategy and prediction enhanced the performance of most algorithms. ClinPred and MetaRNN showed higher predictive potential. This study may provide insights into the evaluation of variants in CCDC22-related diseases.

Indexed as

EpilepsyIntellectual DisabilityNeurodevelopmental DisordersAlgorithmsGenetic TestingHumansMutation, MissenseProtein Interaction MapsCCDC22ClinPredin silico toolsMetaRNNmissense variantoptimizing genetic diagnosis

Identifiers

PMID42339958
PMCPMC13292020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.